FUTURE OF pharmacovigilance
WORLD TOUR 2026

WhySummit’s Pharmacovigilance Conference in Boston exceeded expectations for all. As chair, I was impressed by the intimate scale and quality of interactions given how tricky it can be to strike the right balance of being large enough to bring together diverse perspectives and new connections, yet small enough to foster meaningful dialogue and substantive interactions. Both sponsors and attendees valued lively discussions that went beyond typical sessions (and without being overly ‘salesy’). Lubos and his team deserve credit for curating a program that was both informative and interactive, creating an environment where PV professionals could truly connect, share and learn from each other. Looking forward to next year!

The event was incredibly well-organized, and we enjoyed both the thoughtful conversations and the chance to connect with others in the industry. Your efforts in bringing together leaders in drug safety to drive meaningful dialogue do not go unnoticed, and we are grateful to have been a part of it. Thank you again for your kind invitation and for making the experience such a great one. I look forward to staying in touch and continuing the conversation!

Excited to have participated in the American Drug Safety Summit in Boston, MA! 🌟 It was an honor to highlight the successful partnerships and collaborations between our Safety and Social teams over the past couple of years as well as connect and learn from with industry Subject Matter Experts. A key takeaway for me: AI is coming/ AI is now- How can we utilize this tool, not only to bring efficiencies into our work, but also focus on value-add and increasing quality of work? Thank you to Alison Purdon for your sponsorship and mentorship over the past several years and inviting me to join in on this opportunity! Thank you to Lubos K.and the #WhySummits team for all of your partnership and efforts creating a memorable event!

I heard great things about the event from those who attended, and those who didn’t manage to attend this year regret.

Fabulous meeting today, Lubos. This is a fabulous opportunity for us to shape the future, not just that we can be the conduit to current advances, but we can go beyond that with our military grade solutions.

This event provided great opportunity to network with Industry peers & thought leaders and explore new ways of working. Especially in the new AI era; “on  how Pharmacovigilence industry is progressing and how we need to adapt to the change”. Insights from presentations and panel discussions are adorable . I left with great ideas and new connections in my network to collaborate with and grow further.

Attending this year American Drug Safety Summit 2025 in Boston by Why Summits was an absolute discovery for me. Attendees were not numerous but they represented top-notch leaders from pharma industry in the EU and USA. Discussions were so exciting and constructive – I enjoyed every moment of it. I am truly grateful to Jan, Lubos and Zuzana for such a smart planning of this important event.

I want to express my gratitude to Lubos and the Why Summits team for a well-organized and informative Pharmacovigilance event. The comprehensive agenda, featuring a variety of expert presenters and engaging panel discussions, provided valuable insights and fostered productive networking. I’m eager to participate in future Why Summits events.

The American Drug Safety Summit 2025 was a great event to learn from industry experts about the evolution of patient safety. It was very interesting to see how AI is being leveraged in data-intensive projects to improve patient outcomes. The introduction to the REMS Industry Consortium was a highlight, and their work is truly inspiring.

The conference fosters invaluable connections and drives meaningful collaboration, offering an engaging platform for dynamic interactions within Global Pharmacovigilance & Risk Management, exchange of ideas, and shared growth among participants to ensure patient safety and regulatory compliance.

I thoroughly enjoyed participating in the Why Summits pharmacovigilance conference. The topics were not only timely and relevant but also deeply engaging, sparking meaningful discussions. I especially appreciated the collaborative atmosphere, which created a great opportunity to connect with colleagues across the field and exchange valuable insights.

Participating in the American Drug Safety Summit was a truly rewarding experience. The energy in the room, the depth of conversations, and the shared commitment to transforming pharmacovigilance made it an inspiring and impactful event. I walked away with new perspectives, meaningful connections, and a strong sense of momentum for what’s ahead.

I thoroughly enjoyed the interactive and spontaneous discussions on key pharmacovigilance topics, ranging from Gen AI to PV regulatory frameworks. The conference brought together a focused group of PV professionals, providing ample opportunities to connect and network with like-minded individuals. Overall, it was a successful conference and met its objectives.